[BRIEFING.COM] The stock market trades at its best levels of the day, with the S&P 500 currently up 0.2%.
The healthcare sector (+1.0%) is the top performer in today's market, and is now less than 0.5% away from entering positive year-to-date territory.
Moderna (MRNA 33.88, +1.09, +3.3%) has seen positive growth after the company announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for Spikevax, the company's COVID-19 vaccine, in children 6 months through 11 years of age who are at increased risk for COVID-19 disease. The Company's COVID-19 vaccine, mRNA-1273, was previously available for pediatric populations under Emergency Use Authorization.
Shares of other vaccine developers such as Johnson & Johnson (JNJ 158.48, +2.20, +1.4%) and Pfizer (PFE 25.96, +0.40, +1.6%) have also risen in today's session.